GIUDICE, VALENTINA
 Distribuzione geografica
Continente #
AS - Asia 3.963
NA - Nord America 3.541
EU - Europa 2.318
SA - Sud America 305
AF - Africa 52
Continente sconosciuto - Info sul continente non disponibili 8
OC - Oceania 8
Totale 10.195
Nazione #
US - Stati Uniti d'America 3.505
HK - Hong Kong 2.637
SG - Singapore 607
IT - Italia 600
DE - Germania 521
RU - Federazione Russa 438
CN - Cina 297
BR - Brasile 278
FI - Finlandia 241
VN - Vietnam 127
IE - Irlanda 124
UA - Ucraina 117
TR - Turchia 70
KR - Corea 69
IN - India 68
GB - Regno Unito 61
AT - Austria 54
SE - Svezia 45
CZ - Repubblica Ceca 39
CA - Canada 25
ET - Etiopia 23
NL - Olanda 23
BD - Bangladesh 17
JP - Giappone 17
PL - Polonia 13
ES - Italia 12
EG - Egitto 10
FR - Francia 9
AR - Argentina 8
EC - Ecuador 8
EU - Europa 8
ID - Indonesia 8
MX - Messico 7
NP - Nepal 7
PK - Pakistan 7
VE - Venezuela 7
AU - Australia 6
ZA - Sudafrica 6
JO - Giordania 5
UZ - Uzbekistan 5
AE - Emirati Arabi Uniti 4
KE - Kenya 4
MK - Macedonia 4
TH - Thailandia 4
IQ - Iraq 3
LU - Lussemburgo 3
MA - Marocco 3
BE - Belgio 2
CO - Colombia 2
DZ - Algeria 2
HN - Honduras 2
HR - Croazia 2
HU - Ungheria 2
LY - Libia 2
NZ - Nuova Zelanda 2
AL - Albania 1
BA - Bosnia-Erzegovina 1
CH - Svizzera 1
GE - Georgia 1
GR - Grecia 1
GT - Guatemala 1
IL - Israele 1
IR - Iran 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LK - Sri Lanka 1
LT - Lituania 1
MD - Moldavia 1
MY - Malesia 1
NI - Nicaragua 1
OM - Oman 1
PE - Perù 1
PH - Filippine 1
PY - Paraguay 1
RS - Serbia 1
SA - Arabia Saudita 1
SI - Slovenia 1
SN - Senegal 1
TJ - Tagikistan 1
TN - Tunisia 1
Totale 10.195
Città #
Hong Kong 2.632
Ann Arbor 465
Chandler 453
Munich 390
Woodbridge 326
Princeton 305
Ashburn 276
Singapore 261
Wilmington 188
Houston 157
Jacksonville 148
Helsinki 144
Naples 117
Dong Ket 112
Dublin 108
Moscow 88
Beijing 79
Nuremberg 65
Salerno 63
Andover 57
Izmir 57
Los Angeles 51
Boardman 43
Turku 40
Rome 39
Brno 36
Redwood City 35
Nanjing 34
Washington 33
Dallas 30
São Paulo 24
Addis Ababa 23
Pellezzano 23
Pune 23
Fisciano 22
Milan 22
Vienna 22
Santa Clara 21
Brooklyn 18
Düsseldorf 18
Fairfield 18
Changsha 17
Jyväskylä 17
New York 17
Columbus 16
Rio de Janeiro 15
Seattle 15
The Dalles 15
Norwalk 14
Amsterdam 13
Council Bluffs 13
Manchester 13
Lappeenranta 12
Nanchang 12
Belo Horizonte 11
Guangzhou 11
Tianjin 11
West Jordan 11
London 10
Warsaw 10
Boston 9
Chennai 9
San Francisco 9
Tokyo 9
Toronto 9
Cambridge 8
Cava de' Tirreni 8
Domicella 8
Shenyang 8
Stockholm 8
Buffalo 7
Caserta 7
Catania 7
Charlotte 7
Kathmandu 7
Phoenix 7
Quito 7
Richmond 7
Shanghai 7
Atlanta 6
Chicago 6
Curitiba 6
Dearborn 6
Dhaka 6
Montreal 6
Pisa 6
San Prisco 6
Amman 5
Cava De' Tirreni 5
Edinburgh 5
Fort Worth 5
Jiaxing 5
Juiz de Fora 5
Mercato San Severino 5
Napoli 5
Piacenza 5
Rochester 5
San Diego 5
Turin 5
Zhengzhou 5
Totale 7.580
Nome #
Combination of Ruxolitinib and Eculizumab for Treatment of Severe SARS-CoV-2-Related Acute Respiratory Distress Syndrome: A Controlled Study 816
Hodgkin Lymphoma and Hairy Cell Leukemia Arising from Chronic Lymphocytic Leukemia: Case Reports and Literature Review 337
Suitability of Different Cytological Preparations for Molecular Analysis of Advanced Non-Small Cell Lung Cancers 337
Involvement of soluble forms of receptor of the urokinase-type plasminogen activator (UPAR) in hematopoietic stem cell homing 257
A Rare Immune-Related Mesenteric and retroperitoneal serositis in a Multi-Refractory Hodgkin Lymphoma Patient Successfully Treated with Chylolymphostatic Surgery 224
Mucosal-Associated Invariant T Cells in T-Cell Non-Hodgkin Lymphomas: A Case Series 221
Aplastic anemia: Pathophysiology 185
Giant plasma cells with multiple immature nuclei in a young woman with newly diagnosed multiple myeloma 182
Post-therapy B regulatory cells might early predict relapse in Hodgkin lymphoma 173
Gender Differences in the Impact of COVID-19 Pandemic on Mental Health of Italian Academic Workers 145
Autologous And Allogeneic Stem Cell Transplantation Is Associated With Long-Lasting Endocrine Disorders 143
Accelerated and persistent bone loss after autologous and allogeneic stem cell transplantation 136
Lenalidomide-Mediated NK Cells Expansion In Elderly Multiple Myeloma Patients 136
High incidence of cytomegalovirus reactivation in patients with lymphoma treated with bendamustine 136
Continuous maintenance therapy with alternate-day low dose lenalidomide in multiple myeloma patients after autologous stem cell transplantation increases the number of circulating natural killer cells 127
Anaplastic CD30+ alk- (micro) lymphoma arising out of mediastinal Plasma Cell Castleman’s disease in immunocompetent patient treated by rituximab- dexametasone and continuous lenalidomide 123
Prolonged low-dose lenalidomide treatment increases the number of circulating natural killer cells in multiple mieloma patients 120
Low-Density Granulocytes Are Decreased in Acute Myeloid Leukemia and in Myelodysplastic Syndromes with Negative Prognostic Factors 119
Prolonged azacitidine treatment in the management of elderly patients with high risk myelodysplastic syndromes, chronic myelomonocytic leukemia and acute myeloid leukemia not eligible for standard intensive therapy 114
Prophylactic therapy with oral low-dose valgancyclovir in cytomegalovirus-positive allogeneic stem cell transplant recipients 112
67 KDA laminin receptor (67LR) in normal and neoplastic hematopoietic cells: is its targeting a feasible approach? 109
Bone marrow mesenchymal stem cells as a possible ruxolitinib reservoir in the bone marrow niche 108
Induction therapy with continuous alternate-day low dose lenalidomide combined with low-dose prednisone in octogenarian Multiple Myeloma patients 105
Efficacy and safety of splenectomy in adult autoimmune hemolytic anemia. 105
Continuous maintenance therapy with alternate-day low dose lenalidomide in multiple myeloma patients after autologous stem cell transplantation 101
Cytomegalovirus reactivation prophylaxis with low dose valgancyclovir after hematopoietic stem cell transplantation 101
Daily low-dose valgancyclovir is safe and effective CMV-reactivation prophylaxis in HLA-identical sibling hematopoietic stem cell transplantation. Bone Marrow Transplantation 100
Urokinase type plasminogen activator receptor (UPAR) as a new therapeutic target in cancer. 99
Sirt-1 as a novel therapeutic target for improving nitric oxide release in heterozygous and homozygous patients for mthfr mutations 95
Flow Cytometric Detection Of B-cell Membrane Markers CD5, CD11c, CD20, CD38 And CD49d May Predict Outcome In Chronic Lymphocytic Leukemia And Non-Hodgkin Lymphoma 94
Effects of selected preanalytical variables on Dried Blood Spot (DBS) and Volumetric Adsorptive Microsampling (VAMS) based bioanalytical methods for the determination of four β-lactam antibiotics 92
Endocrine disorders after autologous and allogeneic stem cell transplantation 92
The Role of B Regulatory Cells in the Immunological Escape of Tumor Cells in Hodgkin Lymphoma 91
In vitro apoptotic effects of farnesyltransferase blockade in acute myeloid leukemia cells. 90
Endocrinopathies after allogeneic and autologous transplantation of hematopoietic stem cells. 86
Reproductive issues in patients undergoing Hematopoietic Stem Cell Transplantation: an update 86
Prolonged complete hematologic response in relapsed/refractory T-large granular lymphocyte leukemia after bendamustine treatment. 85
Role of Laparoscopic Splenectomy in Elderly Immune Thrombocytopenia. 84
Pre- and Post-COVID-19 Antibiotic Consumption and Stewardship Program in a Southern Italian Hospital 80
3D Biomimetic Scaffold for Growth Factor Controlled Delivery: An in-vitro study of Tenogenic events on Wharton’s Jelly Mesenchymal stem cells 78
Therapeutic drug monitoring might identify poor responders to ruxolitinib treatment in myeloproliferative neoplasms 77
Immature forms of low density granulocytes are increased in acute myeloid leukemia and myelodysplastic syndromes 75
Combined liposomal amphotericin b and surgery as successful management for pulmunary mucormycosis in a patient with acute myeloid leukemia 75
WT1 Expression Levels Combined with Flow Cytometry Blast Counts for Risk Stratification of Acute Myeloid Leukemia and Myelodysplastic Syndromes 75
Cell-free regenerative medicine: identifying the best source of mesenchymal stem cells for skin therapy in Systemic Sclerosis 74
Real-world evidence of cytomegalovirus reactivation in non-Hodgkin lymphomas treated with bendamustine-containing regimens 72
Aptamers and Antisense Oligonucleotides for Diagnosis and Treatment of Hematological Diseases 71
Low-dose valgancyclovir as cytomegalovirus reactivation prophylaxis in allogeneic hematopoietic stem cell transplantation 70
High-Risk Genetic Multiple Myeloma: From Molecular Classification to Innovative Treatment with Monoclonal Antibodies and T-Cell Redirecting Therapies 69
Low-dose valgancyclovir as cytomegalovirus reactivation prophylaxis in allogeneic haematopoietic stem cell transplantation. 67
Bone Marrow Failure Syndromes, Overlapping Diseases with a Common Cytokine Signature 66
Stem cell and macrophage roles in skeletal muscle regenerative medicine 65
Contribution of peripheral blood mononuclear cells isolated by advanced filtration system to myogenesis of human bone marrow mesenchymal stem cells co-cultured with myoblasts 64
SIRT1 pharmacological activation rescues vascular dysfunction and prevents thrombosis in MTHFR deficiency 60
Daily low-dose valgancyclovir is safe and effective CMV-reactivation prophylaxis in HLA-identical sibling hematopoietic stem cell transplantation 60
How to Improve the Definition of Chronic Lymphocytic Leukemia Outcome Using a Simple Flow Cytometric Score Based on CD49d and Homing Marker Expression 60
Chondrogenic Commitment of human Bone Marrow Mesenchymal Stem Cells in a perfused, hTGF-β1-releasing PLGA microcarrier seeded, collagen hydrogel 60
BONE MARROW MESENCHYMAL STEM CELLS AS FACILITATOR OF RUXOLITINIB-MEDIATED INHIBITION OF JAK2 MUTADED CELLS 60
Immunohistochemical algorithms and gene expression profiling in primary cutaneous B-cell lymphoma 59
A simple flow cytometric score based on CD49d and homing marker expression in chronic lymphocytic leukemia (CLL). 58
Successful management of pulmonary mucormycosis with liposomal amphotericin B and surgery treatment: a case report 57
Cytomegalovirus reactivation is frequent in multiple myeloma patients treated with daratumumab-based regimens 56
Can we turn off the “Covid-biting-tail” inflammation? 56
Real-world experience with the Sydney System on 1458 cases of lymph node fine needle aspiration cytology 56
Identification of uPAR Variants Acting as ceRNAs in Leukaemia Cells 56
Peripheral blood mononuclear cells contribute to myogenesis in a 3D bioengineered system of bone marrow mesenchymal stem cells and myoblasts 55
Pharmacogenetics of Carbamazepine and Valproate: Focus on Polymorphisms of Drug Metabolizing Enzymes and Transporters 55
3D in-vitro cultures of human bone marrow and Wharton’s jelly derived mesenchymal stromal cells show high chondrogenic potential 54
Axitinib in Ponatinib-Resistant B-Cell Acute Lymphoblastic Leukemia Harboring a T315L Mutation 54
Electrophysiological Studies in Combination With Interim-Positron Emission Tomography Scan for Prevention of Severe Brentuximab-Vedotin-Induced Neurotoxicity 53
OPSI threat in hematological patients 53
A case series of blastic plasmacytoid dendritic cell neoplasia 50
Abnormal RNA splicing and genomic instability after induction of DNMT3A mutations by CRISPR/Cas9 gene editing 49
Myogenic commitment of human stem cells by myoblasts Co-culture: a static vs. a dynamic approach 49
Prophylactic letermovir decreases cytomegalovirus reactivation after stem cell transplantation: a single-center real-world evidence study 48
Aptamer-based proteomics of serum and plasma in acquired aplastic anemia 47
Pharmacovigilance of Selective Serotonin Reuptake Inhibitors and Gender Differences in Stroke Incidence 42
Non-invasive prenatal test identifies circulating cell-free DNA chromosomal abnormalities derived from clonal hematopoiesis in aggressive hematological malignancies 40
Lenalidomide-induced psoriasis in a refractory multiple myeloma patient successfully treated with narrowband ultraviolet B 40
c-Kit M541L variant is related to ineffective hemopoiesis predisposing to clonal evolution in 3D in vitro biomimetic co-culture model of bone marrow niche 40
Lymph node fine-needle cytology in the era of personalised medicine. Is there a role? 40
Post-Transplant Cyclophosphamide (PTCY) as GVHD Prophylaxis for Hematopoietic Stem Cell Transplantation From Matched-Related Sibling Donors 40
Single Cell RNA Sequencing and V(D)J Profiling of T-Cell Large Granular Lymphocytosis. 39
Sex-tailored pharmacology and COVID-19: next steps towards appropriateness and health equity 39
Advanced biopolymer filtration system for Peripheral Blood Mononuclear Cells collection: a study on filter composition and in vitro filtrate composition 38
High throughput pSTAT signaling profiling by fluorescent cell barcoding and computational analysis 38
Fluorescent Cell Barcoding for Immunophenotyping 38
Safety of Subcutaneous Daratumumab in Anti-CD38 Monoclonal Antibody-Naïve Patients with Plasma Cell Disorders: A Multicenter Real-Life Experience 37
A Frail Hairy Cell Leukemia Patient Successfully Treated with Pegylated Interferon-α-2A 37
Reduced Proliferative Potential with Conserved Stem/Stromal Phenotype of Human Umbilical Cord Mesenchymal Stem Cells in Placental Syndromes: A Prospective Cohort Study 37
Hemopoiesis and Immune Cell Perturbations during Venetoclax Plus Azacytidine Treatment in Acute Myeloid Leukemia 37
Persistent decreased bone marrow CD3+CD56+ T lymphocytes are inversely associated with mature granulocytes in myelodysplastic syndromes 37
Eltrombopag monotherapy can improve hematopoiesis in patients with low to intermediate risk-1 myelodysplastic syndrome 37
Stem Cells from Healthy and Tendinopathic Human Tendons: Morphology, Collagen and Cytokines Expression and Their Response to T3 Thyroid Hormone 37
Implementation of International Prognostic Index with flow cytometry immunophenotyping for better risk stratification of chronic lymphocytic leukemia 36
Clinical efficacy of azacytidine and venetoclax and prognostic impact of Tim-3 and galectin-9 in acute myeloid leukemia and high-risk myelodysplastic syndromes: A single-center real-life experience 36
Biomimetic proteolipid vesicles for reverting GPI deficiency in paroxysmal nocturnal hemoglobinuria 36
Cardiotoxicity of Novel Targeted Hematological Therapies 36
Inter-intra instrument comparison and standardization of a 10-color immunophenotyping for B and T cell non-Hodgkin lymphoma diagnosis and monitoring 36
Serum Free Light-Chain Ratio at Diagnosis Is Associated with Early Renal Damage in Multiple Myeloma: A Case Series Real-World Study 35
Totale 9.117
Categoria #
all - tutte 40.039
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 40.039


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021504 0 29 25 2 103 28 42 11 29 39 58 138
2021/2022569 14 2 14 43 16 15 4 17 72 46 75 251
2022/20231.182 94 108 85 129 111 209 54 122 155 4 58 53
2023/2024921 77 90 73 59 71 162 71 71 17 40 53 137
2024/20252.716 76 36 42 84 173 277 662 249 447 122 253 295
2025/20262.980 1.420 1.560 0 0 0 0 0 0 0 0 0 0
Totale 10.481